Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome
Henrik Zetterberg, Anders Svenningsson
Abstract
Henrik Zetterberg, Anders Svenningsson
Abstract
Clinically isolated syndrome (CIS) refers to a first episode of multiple sclerosis (MS)–like neurologic symptoms that lasts at least 24 hours followed by complete or partial recovery. Individuals who experience CIS may or may not go on to develop MS. The most notable risk factors for MS during follow-up are MRI lesions and CSF oligoclonal bands.1 More recently, CSF neurofilament light (NfL) concentration, a general marker of axonal injury, has been proposed as predictive of future MS in CIS.2
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Clinically isolated syndrome (CIS) refers to a first episode of multiple sclerosis (MS)–like neurologic symptoms that lasts at least 24 hours followed by complete or partial recovery. Individuals who experience CIS may or may not go on to develop MS. The most notable risk factors for MS during follow-up are MRI lesions and CSF oligoclonal bands.1 More recently, CSF neurofilament light (NfL) concentration, a general marker of axonal injury, has been proposed as predictive of future MS in CIS.2
Key concepts: Multiple sclerosis, Clinically isolated syndrome, Medicine, Neurofilament, McDonald criteria, Pathology, Internal medicine, Immunology